This unique aspect of research, combined with the growing evidence of PSAT1 oncogenic regulation in solid tumor pathogenesis and metastasis [34, 35], suggests that PSAT1 might play a potential role in the immune modulation in MDS cells. Here, PSAT1 is linked to myelodysplastic syndrome.